PhRMA has published this year’s Biopharmaceutical Profile. The report highlights key industry trends, such as prescription drug pricing policy measures, product access challenges, pharmaceutical innovation, and the impact of COVID-19.
“The Profile has told the story of the biopharmaceutical industry for nearly five decades. It outlines the industry’s principles, highlights PhRMA’s key policy solutions, and provides an advocacy toolkit making the case for a more robust, resilient, affordable and equitable health care system for all.” Read more here.
(Source: Gabby Migliara, PhRMA, 9/20/21)